Q: I noticed that Sangoma Technologies Q2 results came in quite a bit higher than both analyst estimates. Would you expect target upgrades forthcoming and therefore a positive impact on the stock price?
You can view 3 more answers this month. Sign up for a free trial for unlimited access.
Investment Q&A
Not investment advice or solicitation to buy/sell securities. Do your own due diligence and/or consult an advisor.
Q: Hi there,
Thanks for your great service. Could I please have your opinion on the Q results from Sangoma?
Thanks!
Thanks for your great service. Could I please have your opinion on the Q results from Sangoma?
Thanks!
Q: Hi Peter , can you please help me out to understand this two co . My risk factor and their recent reports . Would it be a buy in cash acct. I also have room in my tfac acct.Thanks . Alnoor
Q: Sangoma Technologies seems to finally getting the attention it deserves. It was recently a Top Pick on BNN - Market Call. Despite the stock price run up as of late, is it still a buy based on current valuation levels, analyst targets and fiscal 2019 expected results?
Q: What are your thoughts about Sangoma's acquisition this morning? Stock seems very undervalued. Will bigger investors start looking at this Company now, given the analyst coverage, and 12 months sales over $60 million and and very profitable?
Q: I hear Cormark Securities started research coverage on Sangoma Technologies today with a Buy $1.50 target. Beacon Securities already covers the Company with a Buy $1.55 target. Do you think the addition of Cormark will get more attention to the stock given the stellar results and a very cheap current stock valuation? In other words does 2 analysts make a difference now?
Q: Sangoma Technologies released Q1 FY 2018 results this evening. Q1 looked really strong and the share valuation seems very inexpensive for Company with this growth rate, that is profitable and has a strong balance sheet. Your thoughts on STC, its current valuation and would it be a future consideration for the 5i growth portfolio given its 2018 annual sales are guided to exceed $46 million?
Q: What was the consensus for Q1's sales ebitda and eps?
Also, please comment on the Q.
thanks
Also, please comment on the Q.
thanks
Q: Can you please comment on YE results and 2018 guidance just released? What do you think about the company's valuation and growth outlook? Thanks
Q: Can you comment on STC's preliminary q4 numbers. How does the company look go foward? Thanks
-
Sangoma Technologies Corporation (STC)
-
Helius Medical Technologies Inc. Class A common shares (HSM)
-
Pioneering Technology Corp. (PTE)
-
TeraGo Inc. (TGO)
Q: these four stocks and two others symbols AT and PTO
How would you rate them from best to least and are they worth the risk for a risk based long term growth portfolio
How would you rate them from best to least and are they worth the risk for a risk based long term growth portfolio
Q: Hello 5i,
There appears to be a large seller dumping shares of STC through a TD brokerage account. I noticed other insiders had been buyers very recently in the low 80 cent range. Do you think this is a decent opportunity to buy some shares on the dip? I currently have a half position in STC as part of a small/micro cap growth portfolio. Thanks.
There appears to be a large seller dumping shares of STC through a TD brokerage account. I noticed other insiders had been buyers very recently in the low 80 cent range. Do you think this is a decent opportunity to buy some shares on the dip? I currently have a half position in STC as part of a small/micro cap growth portfolio. Thanks.
Q: Sangoma made a sizable acquisition this morning with little dilution. According to management comments they expect revenues to reach $45 million in Fiscal 2018. Stock seems cheap on a revenue multiple? Your thoughts?
Q: I see that Beacon Securities launched research coverage on Sangoma Technologies today with a $1.50 target and the trading volume jumped. Is attracting their first analyst a significant step to bring more attention to Sangoma.
Q: Sangoma Technologies released fiscal Q3 results this evening. Revenues have grown for the eight consecutive quarter, 29% this past quarter. The Company stated in the earnings release that total revenues for fiscal 2017 will now exceed their guidance of $25 million. As the market cap grows (today still trading less than 1X sales) do you think this Company would be considered for your model growth portfolio?
Q: I am tempted to add to my position in Sangoma Technologie prior to Company reporting their quarterly results later this month because I think the market will start taking more notice of this Company given that its revenue run rate is climbing over $25 million and its EBITDA margins (10.5% last quarter) are now growing too. Based on the Company's new guidance for Fiscal 2018 the stock trades less than 1 times sales with profits on the rise and a good balance sheet. What are your thoughts and is this Company on the cusp to be discovered by more investors since the new management re positioned the Company over the last several years?
Q: What is your thoughts about the results and outlook for Sangoma? The stock looks cheap for a Company with $25 million in sales which is expected to grow 15-20%?
Q: any updates on this micro cap.Thanks
Q: Can you give me any information you have on this small,small cap.Thanks